InsidersTradesSigma
Track the Expres2ion Biotech Holding AB stock price and the full management transaction log of the company, a publicly traded company based in Finland. Shares are quoted on the FI market, under the oversight of FIN-FSA. Operating in the Health Care sector, Expres2ion Biotech Holding AB has logged 9 public disclosures. Market capitalisation: €13.9m. The latest transaction was disclosed on 6 July 2026 (Purchase). Among the most active insiders: Bent Frandsen. The full history is openly available.
9
Insider Decl.
n/a
Thresholds
€38,078
6 ops.
Buy Volume
€61,987
2 ops.
Sell Volume
41Σ signal
Fundamental score
Ranked 29,033 of 29,064 companies
2.4
score / 100
Value1
Quality4
FCF yld-132%
Earn yld-123%
EV/EBITDA·
ROE-85%
Gross mgn3.7%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 6 July 2026
Declarations9 total
225,615 shares0WarrantFI:csv-a2e2990c7cc1368134a1
225,615 shares0WarrantFI:csv-7a7a9299d43026ed6d58
356,234 shares0WarrantFI:csv-c23f3b5cfe44f3811143
89,407 shares@ €0.14730.064% mcap100.0% of flowBTU (betald tecknad unit)ISIN SE0019925017FI:A003Y213-1
156,250 shares@ €0.14760.11% mcap100.0% of flowBTU (betald tecknad unit)ISIN SE0028501155FI:A003Y068-1
12,500 shares@ €0.14760.0089% mcap100.0% of flowBTU (betald tecknad unit)ISIN SE0028501155FI:A003Y075-1
192,125 shares@ €0.00020.0002% mcap100.0% of flowTeckningsrätt/UniträttISIN SE0028501148FI:A003Y059-1
2,625 shares@ €1.32920.017% mcap100.0% of flowAktieISIN SE0023261292FI:A003S790-1
15,000 shares@ SEK 42.00100.0% of flowAktieISIN SE0008348262FI:A001R218-1
9 of 9 declarations
关于 Expres2ion Biotech Holding AB
Expres2ion Biotech Holding AB 是一家专注于开发生物制药解决方案的公司。它专门生产用于治疗应用的重组蛋白。